Long-tErm Follow-uP of antithrombotIc Management Patterns In Acute CORonary Syndrome Patients in Asia

Acute Coronary Syndrome Clinical Trial

— EPICOR ASIA  

Official title:

Long-Term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Asia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01361386
• Other study ID #: NIS-CAP-XXX-2011/1
• Status: Completed
• Phase: N/A
• First received: May 23, 2011
• Last updated: June 13, 2014
• Start date: June 2011
• Est. completion date: May 2014

Study information

• Verified date: June 2014
• Source: AstraZeneca
• Contact: n/a
• Is FDA regulated: No
• Health authority: Vietnam: Ministry of Health
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to describe the short-and long-tern (i.e. up to 2 years following the index event) AMPs in patients hospitalized for an acute coronary syndrome (i.e. STEMI or NSTE-ACS), and to document clinical outcomes, economic aspects and impact on quality of life of these AMPs in a 'real-life' setting.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 13011
• Est. completion date: May 2014
• Est. primary completion date: May 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Written informed consent has been provided.

• Diagnosis of STEMI, NSTEMI or UA

• Hospitalization for the first time within 48 hours of onset of symptoms.

Exclusion Criteria:

• UA, STEMI, NSTEMI precipitated by or as a complication of surgery, trauma, or GI bleeding or post-PCI UA, STEMI and NSTEMI occurring in patients already hospitalized for other reasons.

• Current participation in a randomised interventional clinical trial.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Acute Coronary Syndrome
• Syndrome

Locations

Country	Name	City	State
China	Research Site	Baoding	Hebei
China	Research Site	Beijing	Beijing
China	Research Site	Changchun	Jilin
China	Research Site	Changsha	Hunan
China	Research Site	Changzhi	Shanxi
China	Research Site	Chengdu	Sichuan
China	Research Site	Chongqing	Chongqing
China	Research Site	Daqing	Heilongjiang
China	Research Site	Foshan	Guangdong
China	Research Site	Fuzhou	Fujian
China	Research Site	Guangzhou	Guangdong
China	Research Site	Guiyang	Guizhou
China	Research Site	Hangzhou	Zhejiang
China	Research Site	Harbin	Heilongjiang
China	Research Site	Hefei	Anhui
China	Research Site	HongKong
China	Research Site	Jinan	Shandong
China	Research Site	Jinzhong	Shanxi
China	Research Site	Jinzhou	Liaoning
China	Research Site	Kunming	Yunnan
China	Research Site	Lanzhou	Gansu
China	Research Site	Nanjing	Jiangsu
China	Research Site	Nanning	Guangxi
China	Research Site	Ningxia
China	Research Site	Qingdao
China	Research Site	Shanghai	Shanghai
China	Research Site	Shenyang	Liaoning
China	Research Site	Shenzhen	Guangdong
China	Research Site	Shihezi	Xinjiang
China	Research Site	Shijiazhuang	Hebei
China	Research Site	Shiyan	Hubei
China	Research Site	Taiyuan	Shanxi
China	Research Site	Tangshan	Hebei
China	Research Site	Tianjin	Tianjin
China	Research Site	Urumuqi	Xinjiang
China	Research Site	Wuhan	Hubei
China	Research Site	Wuhu	Anhui
China	Research Site	Wuxi	Jiangsu
China	Research Site	Xi'an	Shaanxi
China	Research Site	Xining	Qinghai
China	Research Site	Xuzhou	Jiangsu
China	Research Site	Yingkou	Liaoning
China	Research Site	Yulin	Guangxi
China	Research Site	Zhengzhou	Henan
China	Research Site	Zhenjiang	Jiangsu
India	Research Site	Ahmedabad	Gujarat
India	Research Site	Ajmer	Rajasthan
India	Research Site	Aurangabad	Maharashtra
India	Research Site	Bangalore	Karnataka
India	Research Site	Baroda	Gujarat
India	Research Site	Bhopal	Madhya Pradesh
India	Research Site	Bilaspur	Madhya Pradesh
India	Research Site	Chennai	Tamil Nadu
India	Research Site	Coimbatore	Tamil Nadu
India	Research Site	Delhi
India	Research Site	Gurgaon	Haryana
India	Research Site	Guwahati	Assam
India	Research Site	Hyderabad	Andhra Pradesh
India	Research Site	Jaipur	Rajasthan
India	Research Site	Kochi	Kerala
India	Research Site	Kolkata	West Bengal
India	Research Site	Lucknow	Uttar Pradesh
India	Research Site	Ludhiana	Punjab
India	Research Site	Madurai	Tamil Nadu
India	Research Site	Manipal	Karnataka
India	Research Site	Mohali	Punjab
India	Research Site	Mumbai	Maharashtra
India	Research Site	Nagpur	Maharashtra
India	Research Site	Pune	Maharashtra
India	Research Site	Surat	Gujarat
India	Research Site	Trivandrum	Kerala
Korea, Republic of	Research Site	Bucheon	Gyeonggi-do
Korea, Republic of	Research Site	Busan
Korea, Republic of	Research Site	Cheonan	Chungcheongnam-do
Korea, Republic of	Research Site	Chuncheon
Korea, Republic of	Research Site	Deagu
Korea, Republic of	Research Site	Goyang-si	Gyeonggi-do
Korea, Republic of	Research Site	Gwangju
Korea, Republic of	Research Site	IKsan	Jeollabuk-do
Korea, Republic of	Research Site	Jeju
Korea, Republic of	Research Site	Pusan
Korea, Republic of	Research Site	Seoul
Korea, Republic of	Research Site	Suwon	Gyeonggi-do
Korea, Republic of	Research Site	Yangsan	Gyeongsangnamdo
Malaysia	Research Site	Penang
Malaysia	Research Site	Sarawak	Kuching
Singapore	Research Site	Singapore
Thailand	Research Site	Bangkoknoi	Bangkok
Thailand	Research Site	Huaykwang	Bangkok
Thailand	Research Site	Klongluang	Pathumthani
Thailand	Research Site	Muang	Phitsanulok
Thailand	Research Site	Muang	Songkla
Thailand	Research Site	Muang	Suphanburi
Thailand	Research Site	Muang	Surat Thani
Thailand	Research Site	Muang	Udonthani
Thailand	Research Site	Muang	Chanthaburi
Thailand	Research Site	Muang	Chiangmai
Thailand	Research Site	Muang	Chiangrai
Thailand	Research Site	Muang	Chonburi
Thailand	Research Site	Muang	Khonkaen
Thailand	Research Site	Muang	Lampang
Thailand	Research Site	Muang	Nakornratchaseema
Thailand	Research Site	Muang	Nan
Thailand	Research Site	PathumWan	Bangkok
Thailand	Research Site	Payathai	Bangkok
Thailand	Research Site	Rachathevi	Bangkok
Thailand	Research Site	Saimai	Bangkok
Vietnam	Research Site	Ho Chi Minh City
Vietnam	Research Site	Hue

Sponsors (1)

Lead Sponsor	Collaborator
AstraZeneca

Countries where clinical trial is conducted

China,  India,  Korea, Republic of,  Malaysia,  Singapore,  Thailand,  Vietnam, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	short- and long-term medication and treatment prescribed by physicians in real-life setting		up to 3 years	No
Secondary	clinical outcome (Cardiovascular events)		up to 3 years	No
Secondary	cost of hospitalization		up to 3 years	No
Secondary	quality of life (EQ-5D questionnaire)		up to 3 years	No